Skip to content

Clinical trials

Completed Phase 2 Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20043
20051
20063
20074
20087
20095
20103
20115
20124
20132
20141
20159
20164
20174
20182
20192
20203
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals5
Fred Hutchinson Cancer Center4
National Cancer Institute (NCI)3
Dana-Farber Cancer Institute2
Dey2
Eli Lilly and Company2
Gilead Sciences2
MetrioPharm AG2
St. Petersburg State Pavlov Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome70
Leukemia8
Pulmonary Disease, Chronic Obstructive8
Leukemia, Lymphocytic, Chronic, B-Cell6
Graft vs Host Disease5
Hepatitis C4
Lymphoma, Follicular4
Pain4
Psoriasis4
Respiration Disorders4

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.